Current Value
$518.621 Year Return
Current Value
$518.621 Year Return
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
FMTO | -18.25% | $4.80K | -99.93% | 0.00% |
UUU | -13.75% | $7.19M | +94.38% | 0.00% |
DFDV | -12.27% | $458.02M | +2,978.39% | 0.00% |
PPC | -11.65% | $10.88B | +45.80% | 0.00% |
CBOE | -8.64% | $23.60B | +33.06% | 1.12% |
ALHC | -7.47% | $2.88B | +92.98% | 0.00% |
FDP | -5.78% | $1.59B | +53.95% | 3.33% |
MO | -5.73% | $99.37B | +31.67% | 6.86% |
K | -4.67% | $27.83B | +36.45% | 2.85% |
ATEC | -3.60% | $1.59B | +4.53% | 0.00% |
CARV | -3.57% | $8.54M | +3.12% | 0.00% |
BTCT | -3.11% | $19.82M | +38.12% | 0.00% |
OCFT | -3.08% | $257.92M | +285.16% | 0.00% |
ROOT | -2.91% | $2.17B | +208.61% | 0.00% |
HUSA | -2.78% | $31.37M | +61.29% | 0.00% |
NEUE | -2.29% | $61.16M | +29.49% | 0.00% |
EZPW | -2.24% | $731.68M | +28.88% | 0.00% |
MNOV | -1.73% | $61.80M | -3.82% | 0.00% |
RLX | -1.22% | $2.01B | +22.78% | 0.46% |
CREG | -0.86% | $7.30M | -69.80% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
WEAT | -0.05% | $121.36M | 0.28% |
BSMW | 0.07% | $104.76M | 0.18% |
IEI | 0.23% | $15.27B | 0.15% |
IBTJ | -0.58% | $676.83M | 0.07% |
CTA | 0.74% | $1.09B | 0.76% |
GSST | -0.74% | $899.82M | 0.16% |
KRBN | 0.86% | $166.31M | 0.85% |
FXC | 1.22% | $89.88M | 0.4% |
SHY | -1.44% | $23.90B | 0.15% |
IBND | 1.49% | $349.01M | 0.5% |
STOT | 1.59% | $239.87M | 0.45% |
AGZD | 1.81% | $111.95M | 0.23% |
TPMN | -2.19% | $30.86M | 0.65% |
CANE | -2.20% | $9.88M | 0.29% |
BWX | -2.22% | $1.41B | 0.35% |
IBTK | 2.25% | $433.66M | 0.07% |
IBTG | -2.32% | $1.95B | 0.07% |
USDU | -2.48% | $163.79M | 0.5% |
TFLO | -2.60% | $6.90B | 0.15% |
FTSM | -2.78% | $6.40B | 0.45% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
LIN | 55.39% | $216.96B | +4.75% | 1.25% |
ZTS | 55.20% | $71.98B | -4.71% | 1.20% |
ARW | 55.11% | $6.44B | -1.31% | 0.00% |
OLED | 52.65% | $7.24B | -27.25% | 1.11% |
AVT | 52.45% | $4.29B | -3.22% | 2.55% |
XYL | 52.28% | $30.51B | -10.69% | 1.21% |
SLAB | 52.02% | $4.62B | +19.68% | 0.00% |
RVTY | 51.90% | $11.10B | -12.24% | 0.30% |
AVNT | 51.57% | $3.12B | -22.07% | 3.09% |
A | 51.45% | $32.98B | -13.94% | 0.84% |
FRT | 51.11% | $8.21B | -5.74% | 4.59% |
IT | 51.08% | $31.15B | -9.33% | 0.00% |
LFUS | 51.02% | $5.33B | -17.97% | 1.27% |
EL | 50.84% | $26.91B | -32.49% | 2.31% |
SYNA | 50.79% | $2.43B | -30.33% | 0.00% |
NOVT | 50.57% | $4.40B | -26.11% | 0.00% |
LYB | 50.52% | $19.15B | -37.52% | 9.02% |
MTD | 50.39% | $23.91B | -22.31% | 0.00% |
DD | 50.33% | $28.10B | -16.82% | 2.35% |
TEL | 50.16% | $48.53B | +8.26% | 1.61% |
MarketWatch
IDEXX Laboratories Inc. stock outperforms competitors despite losses on the day
Yahoo
IDEXX Laboratories Inc. (NASDAQ:IDXX) is among the 12 best healthcare stocks. On June 11, Leerink Partners analyst Daniel Clark reiterated an Outperform rating on the stock. However, the analyst increased his stock price target to $580 from $515. According to the analyst IDEXX Laboratories has evolved to become the largest player in the veterinarian space. […]
MarketWatch
IDEXX Laboratories Inc. stock outperforms competitors on strong trading day
SeekingAlpha
BAMCO's Q1 2025 portfolio focuses on long-term growth, with top holdings in Tesla and MSCI. Baron Capitalâs funds continue to outperform benchmarks. See more here.
Yahoo
The main point of investing for the long term is to make money. Furthermore, you'd generally like to see the share...
MarketWatch
IDEXX Laboratories Inc. stock underperforms Monday when compared to competitors
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
FIW | 62.32% | $1.82B | 0.51% |
RSPH | 60.33% | $743.58M | 0.4% |
PAWZ | 59.90% | $62.28M | 0.5% |
MOAT | 59.38% | $12.53B | 0.47% |
XHE | 59.15% | $174.77M | 0.35% |
FXH | 59.13% | $904.53M | 0.62% |
IHI | 59.04% | $4.52B | 0.4% |
QLTY | 59.02% | $1.92B | 0.5% |
FLQM | 58.95% | $1.63B | 0.3% |
RSP | 58.85% | $70.52B | 0.2% |
JQUA | 58.45% | $6.22B | 0.12% |
SIZE | 58.44% | $330.32M | 0.15% |
QQQJ | 58.28% | $603.36M | 0.15% |
DGRW | 58.16% | $15.37B | 0.28% |
NUMV | 57.98% | $366.01M | 0.31% |
HYLB | 57.95% | $3.85B | 0.05% |
GSEW | 57.94% | $1.25B | 0.09% |
VO | 57.90% | $81.57B | 0.04% |
QDF | 57.81% | $1.80B | 0.37% |
HYG | 57.39% | $16.97B | 0.49% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
VIXY | -45.94% | $196.95M | 0.85% |
TAIL | -42.45% | $104.04M | 0.59% |
BTAL | -34.79% | $296.94M | 1.43% |
IVOL | -29.89% | $346.82M | 1.02% |
XONE | -20.66% | $639.76M | 0.03% |
FTSD | -19.09% | $228.45M | 0.25% |
FXY | -16.69% | $859.86M | 0.4% |
KCCA | -13.43% | $98.85M | 0.87% |
BILS | -13.29% | $3.92B | 0.1356% |
ULST | -12.96% | $667.74M | 0.2% |
CLIP | -12.52% | $1.50B | 0.07% |
SPTS | -12.05% | $5.79B | 0.03% |
UTWO | -11.31% | $375.05M | 0.15% |
VGSH | -10.39% | $22.49B | 0.03% |
XHLF | -8.84% | $1.66B | 0.03% |
TBLL | -8.68% | $2.24B | 0.08% |
GBIL | -8.30% | $6.18B | 0.12% |
BILZ | -7.69% | $840.57M | 0.14% |
SCHO | -7.50% | $10.94B | 0.03% |
IBTH | -6.89% | $1.58B | 0.07% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CME | -0.04% | $97.19B | +37.23% | 3.92% |
ETR | 0.05% | $34.88B | +52.72% | 4.36% |
CCEC | 0.16% | $1.02B | +3.91% | 2.67% |
VSA | 0.18% | $8.76M | -14.88% | 0.00% |
LTM | -0.52% | $11.26B | -96.35% | 2.65% |
GALT | 0.56% | $151.27M | +2.58% | 0.00% |
AGL | 0.66% | $869.30M | -68.84% | 0.00% |
TLPH | -0.78% | $9.74M | -39.19% | 0.00% |
CPSH | 0.83% | $36.32M | +44.51% | 0.00% |
CREG | -0.86% | $7.30M | -69.80% | 0.00% |
QNRX | 0.95% | $4.90M | -61.05% | 0.00% |
RLX | -1.22% | $2.01B | +22.78% | 0.46% |
GORV | 1.45% | $25.36M | -92.99% | 0.00% |
MNOV | -1.73% | $61.80M | -3.82% | 0.00% |
LITB | 1.78% | $22.07M | -76.50% | 0.00% |
VHC | 1.82% | $36.03M | +76.35% | 0.00% |
STG | 2.18% | $28.60M | -22.21% | 0.00% |
EZPW | -2.24% | $731.68M | +28.88% | 0.00% |
NEUE | -2.29% | $61.16M | +29.49% | 0.00% |
SRRK | 2.44% | $2.96B | +266.90% | 0.00% |
Double maintains 14 strategies that include IDXX - IDEXX Laboratories, Inc.